Abbott Presents Diagnostic Innovations to Enhance Patient Care at AACC 2022

By LabMedica International staff writers
Posted on 21 Jul 2022

Abbott Diagnostics (Lake Bluff, IL, USA) is offering one-on-one and group demonstrations of its latest diagnostic offerings at the 2022 AACC Clinical Lab Expo, including its next generation of Alinity systems that are designed to simplify diagnostics and help deliver results. In addition, Abbott will be providing demonstrations of its GLP systems Track, AlinIQ Digital Health solutions, hematology, molecular, diabetes care and point of care solutions.

Visitors at the Abbott AACC 2022 booth can learn new ways to achieve measurably better healthcare performance with its personalized core diagnostics solutions consisting of Resourceful Advocates, Harmonized Systems and Intelligent Insights. During its product demonstrations at the event, visitors can explore Abbott's next generation of Alinity systems that uses technology to help redefine and improve operational productivity and confidence in the laboratory. The Alinity family is harmonized across key laboratory disciplines, streamlining critical interactions between individuals, systems and information, and enabling users to redefine performance in the laboratory and across the institution.

Image: Abbott celebrated 50 years of diagnostic innovations at AACC 2022 (Photo courtesy of Abbott)

The Alinity family comprises the Alinity ci-series integrated clinical chemistry & immunoassay system combining up to four modules in multiple configurations to meet the laboratory's needs and maximize operational efficiency. The Alinity c is a compact clinical chemistry system that maximizes testing throughput with high-quality assays to deliver efficient and accurate performance. The ALINITY I is a compact immunoassay system that utilizes proven CHEMIFLEX chemiluminescent detection technology to provide greater confidence in results. The Alinity m is a fully integrated, automated, high-throughput molecular diagnostics analyzer with high-quality assays that delivers the next level of flexibility and efficiency to molecular labs.

At AACC 2022, Abbott is also demonstrating GLP systems Track that allows users to easily modify their track for future changes and maximize floor space while transforming the laboratory from 2D to 3D. GLP systems Track minimizes track implementation time, maximizes uptime with infinite redundancy, optimizes workflow, and decreases turnaround time system to meet the laboratory’s needs. In addition, Abbott will demonstrate how AlinIQ Always On services can help labs achieve operational efficiency and increase productivity by avoiding unexpected downtime. AlinIQ Always On Services utilizes Active Sense Technologies, Resourceful Advocates and Disciplined Processes to offer instrument health monitoring that enables laboratories to achieve operational efficiency and increase productivity.
 

Related Links:
Abbott Diagnostics 


Latest AACC 2022 News